
ãã¡ãŠãæ°ããããŠãããŒãµã«mRNAã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ããèšç»ããŠãããããªãå ¬éãããããããã人ã ãã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ãæããŠããªãã£ããããããããCOVID-19 mRNAã¯ã¯ãã³ãã«ãªã£ãã
ãã©ã€ã¢ã³ã»ã·ã«ããŽã£
ã°ããŒãã«ãªãµãŒãã2021幎10æ6æ¥
å¥åº·åœ±é¿ãã¥ãŒã¹2021幎10æ5æ¥

æšå€ãInfowars.comã®ã¢ã¬ãã¯ã¹ã»ãžã§ãŒã³ãºã¯ã圌ããæè¿ç¥ã£ã2019幎10æã®ãããªã«é¢ããç¹å¥æŸéãè¡ããŸãããããã¯ããã«ã±ã³ç ç©¶æãäž»å¬ãããŠãããŒãµã«ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®å¿ èŠæ§ã«ã€ããŠè°è«ããããã«ãã£ã¹ã«ãã·ã§ã³ã§ããã
ãã®ã€ãã³ãã§æµããããããªã¯ãªããã¯ãåžäŒè ã®ãã€ã±ã«ã»ã¹ãã¯ã¿ãŒæ°ïŒãã¥ãŒãšãŒã«ãŒèªã®èšè ã§ãããã¹ã¿ã³ãã©ãŒã倧åŠã®çç©å·¥åŠã®éåžžå€ææã§ããããžã£ãŒããªã¹ãïŒãåœç«ã¢ã¬ã«ã®ãŒã»ææçç ç©¶ææé·ã®ã¢ã³ãœããŒã»ãã¡ãŠãæ°ãããã³HHSçç©å»åŠå 端ç ç©¶éçºå±ïŒBARDAïŒæé·ã®ãªãã¯ã»ãã©ã€ãæ°ã«ãã1å51ç§ã®å¯Ÿè©±ã ã£ãã
1æéã«åã¶ããã«ãã£ã¹ã«ãã·ã§ã³ããæç²ããããã®çãã¯ãªããã§ã¯ãã¢ã³ãœããŒã»ãã¡ãŠãå士ããmRNAã¯ã¯ãã³ã®ãããªæ°ããæªè©Šéšã®ã¯ã¯ãã³ãå°å ¥ããã«ã¯ãé©åãªè©ŠéšãçµãŠFDAã®æ¿èªãåŸããŸã§ã«å°ãªããšã10幎ïŒããã¹ãŠãå®ç§ã«ããŸãããã°ãïŒãããã ãããšèª¬æããŠããŸãã
圌ãªãç¥ã£ãŠããã¯ãã ããªããªãã圌ã¯åœæïŒ2019幎10æïŒãã§ã«10幎ã»ã©åãããHIVã®mRNAããŒã¹ã®ã¯ã¯ãã³ã®éçºã«åãçµãã§ããããã ã
ãããä»ã圌ãã¯ãšã€ãºæ£è åãã®ã¯ã¯ãã³ãããã¯ããã«å€§ããªããšãè°è«ããŠããã誰ããæ¥çš®ããªããã°ãªããªãããŠãããŒãµã«ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãã«ã€ããŠè©±ããŠããã®ã ãããã¯è£œè¬å€§æã«ãšã£ãŠå·šå€§ãªåžå Žãšãªãã ããïŒ
ãã®åŸãHHSçç©å»åŠå 端ç ç©¶éçºå±ïŒBARDAïŒã®ãªãã¯ã»ãã©ã€ãå±é·ãçºèšãããå®å šã«ç Žå£çã§ãå®åçãªæçžãããã»ã¹ã«çžãããªãåºæ¿çãªçµç¹ããç¶æ³ãå€ããå¯èœæ§ããããšè¿°ã¹ãŠããŸãã
以äžã¯æšå€ãBitchuteãšRumble ã®ãã£ã³ãã«ã«æçš¿ããçãã¯ãªããã§ãã
ã¢ã¬ãã¯ã¹ã»ãžã§ãŒã³ãºã¯æšæ©ã®çªçµã§ãã®ä»¶ã«ã€ããŠ50 å以äžåãäžããŸãããã仿¥ã®çªçµã§ãåãäžããããã§ãã
ç§ã¯ãŸã ããããèŠãæ©äŒããããŸããã§ãããããªãªãžãã«ã® 1 æéã®ããã« ãã£ã¹ã«ãã·ã§ã³ ãããªãæ¢ãããããèããŠåæããããšã« 1 æ¥ãè²»ããããã®ã¬ããŒããèªè ã«æäŸã§ããããã«ããŸããã
ãã®ã€ãã³ãã«ã¯ãã¡ãŠãããªãã¯ã»ãã©ã€ãããã€ã±ã«ã»ã¹ãã¯ã¿ãŒãšãšãã«ä»¥äžã®äººã ãåå ããŸããã
ããŒã¬ã¬ããã»ãã³ããŒã°ãåœç«å»åŠã¢ã«ãããŒå€å倧è£
ãã«ãŒã¹ã»ã²ãªã³ãã»ãŒãã³ã¯ã¯ãã³ç ç©¶æã°ããŒãã«å ç«æ åœç€Ÿé·
ã±ã€ã·ãŒã»ã©ã€ããFluLab CEO
èŠããã«ããã®ããã«ãã£ã¹ã«ãã·ã§ã³ã¯ã圌ããèªèããŠããäžèœã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®å¿ èŠæ§ã«çŠç¹ãåœãŠããã®ã ã£ããã圌ãã¯ãåŸæ¥ã®ã¯ã¯ãã³è£œé æ¹æ³ã§ã¯ç®çãéæã§ãããå€ãã®äººã ãåœãæžããŠäžè¬å€§è¡ã«è©Šéšã§ããæ°ããmRNAã¯ã¯ãã³ãå±éã§ãããããªãããçš®ã®äžççã€ãã³ããå¿ èŠã§ããããšãèªããã
圌ãã¯çãæ¯å¹Žæµè¡ããã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ã¯ãåœæ°ã«äžèœã¯ã¯ãã³æ¥çš®ãå§ããã»ã©æãããåºæ¥äºã§ã¯ãªãããšã«åæããã
ãããŠããã®åºæ¥äºããçŽ2幎åŸã®ä»æ¥ãç§ãã¡ãç¥ã£ãŠããéããæã¡èŸŒãŸãããæããããŠã€ã«ã¹ãã¯COVID-19 SARSãŠã€ã«ã¹ã§ããã
2020ïœ2021幎ã®ã€ã³ãã«ãšã³ã¶ã·ãŒãºã³ã«ã€ã³ãã«ãšã³ã¶ããæ¶ãããçç±ãããã§åãããŸãããã€ã³ãã«ãšã³ã¶ã¯COVID-19ã«åã£ãŠä»£ããããã ãã§ãäžçåã®äžèœmRNAã¯ã¯ãã³ãæ®åãããããã«ãäžçèŠæš¡ã§å·§åŠã«èšç»ãããããã³ãããã¯ãã§ããã
ããã¯åžžã«ç®æšã ã£ããããããŸã§ããŸããŸãªã€ã³ãã«ãšã³ã¶ããšã€ãºããšãã©ããã®ä»ã®ããŠã€ã«ã¹ããéããåãçµã¿ã¯ãå šäžçã®äººã ã«æ³šå ¥ããäžèœã¯ã¯ãã³ã®éçºã«ã€ãªããããšã¯ãªãã£ãã
ããŒã¬ã¬ããã»ãã³ããŒã°æ°ã¯ããŠãããŒãµã«ã¯ã¯ãã³ããåžå Žã«æå ¥ããããšã«ã€ããŠæ¬¡ã®ããã«è¿°ã¹ãŠããŸãïŒ
ãä»ã¯è©±ãã®ããããŠãè¡åããæã ãã
ãããã¯ãç§ãã¡ã«ç·æ¥æããªãã£ãããã§ããããšæããŸããã
ãã€ã±ã«ã»ã¹ãã¯ã¿ãŒã¯ããåããããïŒ
ããã®ç·æ¥æãçããããã«ã¯ãå€ãã®äººãæ»ã¬å¿ èŠãããã®ãââïŒã
ãã³ãã«ã¯æ°ã¯ãæ¯å¹Žã€ã³ãã«ãšã³ã¶ã§äº¡ããªã人ã¯ãã§ã«ããããããŸãããšçããã
ãã«ãŒã¹ã»ã²ãªã³ã¯ãåºæ¬çã«äººã ã¯ãã€ã³ãã«ãšã³ã¶ããšããèšèãããŸãæããŠããªãã ãã ãšè¿°ã¹ãŠããŸãã
ãã®ããã«ãã£ã¹ã«ãã·ã§ã³ã§ã¯ã倧æè£œè¬äŒç€Ÿãšæ¿åºã®ä¿å¥åœå±ã®èãæ¹ãå€ãã®ç¹ã§æããã«ãªããŸãããäŸãã°ã圌ãã¯å ¬è¡è¡çã®åéã§ããéãããšããŠã€ã«ã¹ãšéã補åã®éçºè³éã倱ãããšãåããŠããŸãã
ãã€ã±ã«ã»ã¹ãã¯ã¿ãŒã¯ããè¿°ã¹ãŠããŸãããå ¬è¡è¡çã®äžçã®åªãã®äžã€ã¯ãçãããèªåã®ä»äºããã¡ããšãã£ãŠããã°ãçãé 調ã«å¥åº·ã§ãããããšããããšã ãšæããŸããã
ãã³ãã«ã¯ïŒããããŠåœŒãã¯ããªãæ¹ã®è³éãåæžããŸãããã
ãªãã¯ã»ãã©ã€ãæ°ã¯ãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®æ¯å¹Žã®é åžã¯ããŒã¿åéã®é¢ã§éå¹ççã ãšäžæºãè¿°ã¹ããã®éçšã§ãäžéšã®ã¯ã¯ãã³ã¯å¹æãããŸããªãããšãå®éã«èªããŠããã
ãç§ãã¡ã¯æ¯å¹Ž1å5000äžååã®å£ç¯æ§ïŒã€ã³ãã«ãšã³ã¶ïŒã¯ã¯ãã³ãé åžããŠããŸãããé åžãããã¯ã¯ãã³ããäœäººãæ¥çš®ãåããã®ããã©ã®ã¯ã¯ãã³ãæ¥çš®ããã®ãããããŠå®éã®çµæã¯ã©ãã ã£ãã®ãããææ¡ããŠããŸãããã ããããããã®ç¥èåºç€ããã¯ã¯ãã³ãæé©åãŸãã¯æ¹åããæ¹æ³ãåŠã¶ããšãã§ããã®ã§ããã§ãããã仿¥ç§ãã¡ã«ã¯ãã£ã³ã¹ãããã®ã§ãâŠ
çŸåšåžå Žã§æã广ã®äœãã¯ã¯ãã³ãæŽé²ããã°ãç§ãã¡ãä¿æããæè¡ãã©ããªã®ããæããã«ãªãããããã®æè¡ãããæ·±ãæãäžããŠããªããã广çãªã®ããè§£æã§ãããããããŸãããçŸåšããã广çãªã¯ã¯ãã³ãèªå¯ãããŠããŸããç§ãã¡ã¯ãã çå®ãèªããããšãæããŠããã ãã ãšæããŸããã
倧æè£œè¬äŒç€Ÿãæ¿åºãå±ãããã¯ã¯ãã³ã®ãç§åŠãã¯ã確ç«ãããŠãããããããŠå®å šã«ãå®å šã§å¹æçãã§ãããšããå ¬çãªãã³ãã©ã¯ãããã§çµããã ã
ã±ã€ã·ãŒã»ã©ã€ãæ°ã¯ãCOVID-19ãæµè¡ãã以åããæ¯å¹Žå§äŒãããŠãããã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ã®èŽæ»çã®é«ãã«é¢ãããã³ãã©ãç¹°ãè¿ãããã€ã³ãã«ãšã³ã¶ã§æ¯å¹Ž65äžäººã亡ããªã£ãŠãããã
ãã«ã¹ã€ã³ãã¯ããã¥ãŒã¹ã§ã¯éå»10幎éãäœåºŠãèšäºã«ããŠããããã«ãããã¯å šãã®äºå®ã§ã¯ãããŸãããããã¯æšå®å€ã§ãããå®éã®ã€ã³ãã«ãšã³ã¶ã®æ€æ»ç¢ºå®çäŸã¯æ¯å¹Žéåžžã«å°ãªããç±³åœã§ã¯ãããã1000ä»¶æªæºã§ãã
ã€ã³ãã«ãšã³ã¶æ§çç¶ã®ã»ãšãã©ã¯ããã®åå ãç¹å®ããããã®æ€æ»ãå®éšå®€ã§è¡ãããããšã¯æ±ºããŠãããŸããããããã¯åžžã«ãã€ã³ãã«ãšã³ã¶ããšåé¡ãããæ¯å¹Žéåžžã«å©çã®é«ãã€ã³ãã«ãšã³ã¶ äºé²æ¥çš®ãæ£åœåããããã«ãææè æ°ãæ°Žå¢ãããŠããŸããããã®åé¡ã«é¢ãã以åã®èšäºïŒ CDCãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®å£²ãäžãã䌞ã°ãããã«ã€ã³ãã«ãšã³ã¶ã«ããæ»äº¡è æ°ãæ°Žå¢ãã æšå¹Žã¯æ¬åœã«8äžäººãã€ã³ãã«ãšã³ã¶ã§äº¡ããªã£ãã®ãïŒã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ã売ãããã«ã€ã³ãã«ãšã³ã¶ã«ããæ»äº¡è æ°ãæ°Žå¢ã
ã€ãŸããæšå¹ŽããCOVID-19ã®ææè æ°ãæ°Žå¢ãããŠããã®ãšåæ§ã«ãã¯ã¯ãã³ã売ãããã«ã€ã³ãã«ãšã³ã¶ã®ææè æ°ãæ¯å¹Žæ°Žå¢ããããšããæ¿çãç¶ããŠããã ããªã®ã§ããæšå¹Žããã®äž¡æ¹ãè¡ãããšã¯æããã«äžå¯èœã§ããããªããªããåœæ°ã¯ããã«èšç®ãåããªãããšã«æ°ä»ããŠããããã§ãã
ããã«ãããããããåœæ°ã®å€ãã¯ãCOVID-19察çã«ãã£ãŠã€ã³ãã«ãšã³ã¶ã¯æ²æ» ã§ããããCOVID-19ã¯æ²æ» ã§ããªãã£ããšããåãä¿¡ããŠããŸã£ãã®ã§ãã
çµå±ã®ãšããããã®ããã«ãã£ã¹ã«ãã·ã§ã³ã®ããŒãã¯ã誰ãäžèœã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®ç ç©¶ã«è³éãæäŸããããªããã§ã¯ãã©ãããã°ç¶æ³ãå€ããããã ãããïŒããšããç¹ã«éçŽããããã€ã³ãã«ãšã³ã¶ã«å¯Ÿããææã®ãã³ãããã¯ãäœãåºãã®ã ïŒãã ããã€ã³ãã«ãšã³ã¶ãžã®ææã¯ãã¯ããªããããšã€ãºããžã®ææãèããŠããããããã€ã³ãã«ãšã³ã¶ããšåŒã¶ããšã¯ã§ããªãã£ãïŒã
ãã¡ãŠãæ°ã¯ãã®åŸããã®ãèªèã®åé¡ãã«ã€ããŠèšåããã
ã€ã³ãã«ãšã³ã¶ã«ã€ããŠããããªã«æ·±å»ãªã®ãªããæ¯å¹Žã€ã³ãã«ãšã³ã¶ã«çœ¹ã£ãŠã倧æšäºã«ãªããªãã®ã¯ãªããããšããèªèããããŸãã
HIVã®ãããªç æ°ã®å Žåãææããã°é節ã§ããè¥ããŠããäžå¹Žã§ããé«éœ¢ã§ãé¢ä¿ãããŸãããçã«ãªãã°ãããã¯åä»ã§ããè¥ããŠããäžå¹Žã§ãâŠäžæ¹ãã€ã³ãã«ãšã³ã¶ã®å Žåã¯ãçæ¶¯ãéããŠå šã圱é¿ãåããªã人ãããŸãã
ã€ã³ãã«ãšã³ã¶ãæãã人ã¯ããŸããããã©ãŒã«ã¹ã°ã«ãŒãã§ããªã¹ã¯ãããã®ã«HIVã«ææããã®ã¯æãã§ããïŒããšèããŠã¿ãŠãã ãããããããã¡ããã§ãã
ãããæãã§ããïŒãã¡ããã§ããã€ã³ãã«ãšã³ã¶ãæãã§ããïŒæ§ããªãã§ã
ãããã人ã ãã€ã³ãã«ãšã³ã¶ãã©ãèªèããŠãããã®çŸå®ã§ãã
ãããŠãå éšãããããªãã®èªèã¯æ°ã«ããªããç§ãã¡ã¯ç Žå£çãªæ¹æ³ã§åé¡ã«åãçµã¿ãŸãããšèšããªãéãããããå€ããã®ã¯éåžžã«é£ããã§ããã...
ã¹ãã¯ã¿ãŒã¯æ¬¡ã®ããã«è³ªåããŸãïŒ
é·ãç®ã§èŠãã°ããã2009幎ã®ãã³ãããã¯ããã£ãšèŽåœçãªãã®ã§ãã£ããªããããã¯äººé¡ã«ãšã£ãŠçµå±ã¯ããè¯ãããšã ã£ãã®ã§ããããïŒ
çã¯æããã«ã©ãçããããèããŠããŠé»ã£ãŠããŸããããã¹ãã¯ã¿ãŒã¯èšããŸãããããããã¿ããªãã
ãã¡ãŠãåå£«ã¯æçµçã«ããããããšçããŸããããªããªãã2009 幎ãããæªã幎ããã£ããããŠãããŒãµã«ã¯ã¯ãã³ã®éçºãšããç¹ã§ã¯äœãå€ãã£ãŠããªãã£ãããã§ãã
ãã³ãã«ã¯ã¯æ¬¡ã®ããã«è¿°ã¹ãŠããïŒ
æ²ããçå®ã¯ã倧ããªå±æ©ãèµ·ãããšã泚ç®ãéãŸããéåžžã¯è³æºãæå ¥ãããããªãã®åå¡ãè¡ããããšããããšã§ãã
ãŸã第äžã«ãä»åã¯ãããŸã§ãšã¯éã察å¿ãããå¿ èŠããããŸãããŸããåãªã察å¿ã§ã¯ãªããæç¶çãªè¡åã«å¯Ÿãã責任ãè² ãããããªåœ¢ã§ãç§ãã¡èªèº«ããã£ãããšçµç¹åããå¿ èŠããããŸãã
ã¹ãã¯ã¿ãŒæ°ã¯æ¬¡ã®ããã«è¿°ã¹ãŠããŸãïŒ
ç©è°ãéžã人ç©ã ããç§ã«ãšã£ãŠã¯è峿·±ãã¯ã¬ã€ã°ã»ãã³ã¿ãŒæ°ã¯ãéŠæž¯ããé£è¡æ©ã§é¢éžããŠææããå Žåãé£è¡æ©ããã¥ãŒãšãŒã¯ã«çéžãããŸã§ã«ã¯ã¯ãã³ãçµã¿ç«ãŠãããé åžãããããã«ãªãã¹ãã§ããããšæžããŠããã
ããã¯ãªããŠéŠ¬é¹¿ããããšã§ããããç§ãã¡ã¯ããããã©ããããé ãã®ã§ããããïŒç§ãã¡ã¯ããã«ãã©ãçãããšãã§ããã®ã§ããããïŒ
ãã©ã€ãã¯ããçããïŒ
ã©ããããé ããã¯èšããŸããããããã»ã©é ããšã¯æããŸããã
åæããŒã¹ã®ã¯ã¯ãã³ã®æä»£ã«ç§»è¡ããã°ãã¯ã¯ãã³ã¯åµåã现èãæè«çްèãªã©ä»ã®äœãã«æé·ãããªããã°ãªããªããã€ãŸãããããçš®é¡ã®äŸåèãšèããäŸåæ§ããªããªããšæããŸãã
ããåæçãªæ žé žããŒã¹ãã¡ãã»ã³ãžã£ãŒRNAããŒã¹ã®æè¡ã«ç§»è¡ã§ããã°ããããã®é åã¯äžçäžã§è¿ éã«å ±æã§ããããã«ãªããŸãã
ãã®åŸåœŒã¯ã3Dããªã³ã¿ãŒã䜿ã£ãŠãã¯ã¯ãã³ããæäžããããã«äœ¿ããããã¯ã¯ãã³ãããããå°å·ããããšã«ã€ããŠè©±ãç¶ããŸãã
ãŸãããã®ããã«ãã£ã¹ã«ãã·ã§ã³ã§ã¯ãã¢ã³ãœããŒã»ãã¡ãŠãããªãèªç¶å ç«ã«ããã»ã©å察ããŠããã®ããåãããŸãã圌ã®èŠè§£ã«ããã°ãã€ã³ãã«ãšã³ã¶ã«å¯Ÿããèªç¶å ç«ã¯ãç¹å®ã®ã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ã®ä»ã®æ ªã«å¯Ÿããå ç«åå¿ãæå³ããã¯ã¯ãã³ã§ããããšããŠããããšã劚ããããã§ãã
ã ãããã圌ã¯ãããã§è¿°ã¹ãŠããããã«ãçåŸ6ãæã»ã©ã®ä¹³å ã«ãŠãããŒãµã«ã¯ã¯ãã³ã泚å°ããåäŸãæé·ããåã«ãæ··ä¹±ãããèªç¶å ç«ãçºçããã®ãé²ããããšèããŠããã®ã§ãã
ããã§ããã®ããã«ãåãçµãã 倧ããªåé¡ã¯ã圌ãã¯ã©ã®ããã«æŠç¥ãå®è¡ããã®ãããããŠäœã圌ãã劚ããŠããã®ãããšããããšã§ããã
確ãã«æ¿åº/èŠå¶åœå±ã®åé¡ã¯å€§ããªåé¡ã§ããã2幎åŸã®ä»ã圌ããã©ã®ããã«ãããè¡ã£ãããæ£ç¢ºã«ç¥ãããšãã§ããŸããFDAãšCDCãã³ã³ãããŒã«ããŠã殺人ãŠã€ã«ã¹ã®ãã³ãããã¯ããšããç©èªãå¯èœãªéãåºããæ°ããæ°è¬ãåžå Žã«åºãããã®éåžžã®æé ãççž®ããç·æ¥æªçœ®ãåãããšãæ£åœåããŸããã
ãŸããå®éã«ã¯åãªãå£ç¯æ§ã€ã³ãã«ãšã³ã¶ããŠã€ã«ã¹ããéåžžã«ç°¡åã«æ²»çããäžèœã¯ã¯ãã³ã®å±éãé»ãã§ããæ¢åã®å®äŸ¡ãªæ²»çè¬ã«å¯Ÿããæªæããå察ãæç¢ºã«èª¬æãããŠããã
ã±ã€ã·ãŒã»ã©ã€ãæ°ã¯ãã®åŸããæ åæŽ»åããšããããã®åãçµã¿ã«ãããŠæãã圹å²ã«ã€ããŠãéåžžã«æ³šç®ãã¹ãã³ã¡ã³ããããŸããïŒ
æ åæŽ»åãæããã圹å²ã¯ç¢ºãã«ãããšæããŸããç§ãã¡ã¯ããå°ããªã¹ã¯ãè² ãç«å Žã«ããïŒããèšããšåœŒå¥³ã¯äžæ°å³ãªç¬ã¿ãæµ®ãã¹ãŸãïŒãç©äºã®é²ãæ¹ã«é¢ããŠããå°ãå®éšãææ³ã«ãªãŒãã³ã«ãªããã®ã§ãããããFluLabã®ããããŠä»ã®æ åæŽ»åã®ãŠããŒã¯ãªç¹ã ãšæããŸãã
圌ãã¯ããã§æ¬åœã«éèŠãªåœ¹å²ãæããããã倧èã§ãããããæ©æã«å®çŸå¯èœãªäžé£ã®æ§æ³ã«è³éãæäŸã§ãããšæããŸãã
ãã³ãŽïŒãã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ãããã¯ãã§ã©ãŒè²¡å£ããããŠãã®ä»ã®ãæ åå£äœãã¯ãèŠå¶ã®åé¡ã«ãçžãããããã»ãšãã©ãã§ãã¯ã責任ãè² ããã«è³éããç§åŠããšã瀟äŒå šäœã®å©çãã®åã®äžã«äœ¿ãç¶ããŠããã
ã²ã€ã財å£ãã€ã³ãã§ããããã«ã¹ã€ã³ãã¯ããã¥ãŒã¹ã§é·å¹Žã«ãããäœåºŠãåãäžããŠããã¬ãŒãã·ã«ã¯ã¯ãã³ãªã©ãå«ççã«éåžžã«çåã®ããã¯ã¯ãã³å®éšã«è²§ãã人ã ãèªã蟌ãããšã§ããããã©ã®ããã«è¡ã£ãŠããããç§ãã¡ã¯ç¢ºãã«èŠãŠããŸããã
ãã«ãŒã¹ã»ã²ãªã³æ°ã¯ãã®åŸã圌ã®çµç¹ãçºè¡šããå ±åæžã«ã€ããŠèªãããã®å ±åæžã§ã¯ãããããæ±ºå®ãäžããå šå¡ãéããŠååãããã®äžèœã¯ã¯ãã³ãéçºããå察è ãæé€ãããçµç¹ãã®å¿ èŠæ§ã蚎ããŠããã
ãã®ã¬ããŒãã¯2019幎ã«å ¬éãããŠããããã¡ãããã¬ã¹ãªãªãŒã¹ã§ãã
åœŒã¯æ¬¡ã®ããã«è¿°ã¹ãŠããŸãïŒ
圌ãã¯ãå ã»ã©ã話ããããå®äœããã€ãŸãååäœå¶ã®å¿ èŠæ§ã蚎ããŸãããã€ãããŒã·ã§ã³ãæ³šå ¥ããåé¡ã®äžå ãšãªã£ãŠãããããããªããç§ãã¡ãç¥ããªã人ãã¡ããã®åãçµã¿ã«åå ãããå¿ èŠæ§ã蚎ããŸããããããŠãèè žçã®ããã§ç§ãã¡ã®é²æ©ã劚ããããªãããã«ããã®åé¡ã«ã€ããŠã©ã®ããã«è©±ãåãã°ããã®ããå¥ã®æ¹æ³ãèããããšããŸãããïŒå šå¡ç¬ïŒ
ãã®ãå£äœããšã¯ãã²ãªã³æ°ã®ã°ã«ãŒãã§ãããµãã³ã»ã¢ã¹ãã³ã»ã¯ã¯ãã³ç§åŠã»æ¿çã°ã«ãŒãã§ãããšæãããŸãã
çŸåšããã®ã°ã«ãŒãããã¯ã¯ãã³èºèºããšéãããã®ãŠãããŒãµã«ã¯ã¯ãã³ïŒãã¡ããä»ã§ã¯COVID-19ã¯ã¯ãã³ã§ããããšãåãã£ãŠããïŒã®å°å ¥ãé»ãããããå察æèŠãé»ãããããšããŠããäž»èŠã°ã«ãŒãã ã
ã¯ã¯ãã³ã«é¢ãããªã³ã©ã€ã³äžã®èª€æ å ±
ããã«ãã£ã¹ã«ãã·ã§ã³å šäœãèŠãŠã圌ããããã«å²æ ¢ã§ãããã宿ããŠãã ãããBitchuteãšRumbleãã£ã³ãã«ã§é ä¿¡ããŠããŸã ã
ããªãã®åœã¯ãæªéã®æŽåãã¡ã«ãšã£ãŠå®éšå°ãšããŠã®äŸ¡å€ãããªã
ããã¯ç§ãä»ãŸã§èŠãäžã§æãè¡æçãªãããªã®äžã€ã§ãã°ããŒããªã¹ãæŽåãã¡ã®èãæ¹ãšãã¯ã¯ãã³ã䜿ã£ãŠäººé¡ãæ¯é ããããšãã圌ãã®è²ªæ¬²ãªé¡æãç§ãã¡ã«æããŠãããŸãã
ãããèŠããšãèªåèªèº«ã«åããããå¿ èŠããããŸããå šäººé¡ã«ãšã£ãŠäœãããããæ±ºããããã«ããããã®äººã ã人é¡ã®äžè©±äººãšããŠä»»åœããã®ã¯èª°ã§ãããã?
ãã®å»çã®å°æšªã®åé¡ã®æ ¹åºã«ããã®ã¯ã人çã«å¯Ÿããèãæ¹ã®æ ¹æ¬çãªéãã§ãã
ãã®ããã«ã¯ãçåœã®åµé äž»ã§ããç¥ãå®å šã«æé€ããã«ã·ãã§ãªã¢ã³ãæªéçãªäžç芳ã衚ããŠããŸãã
èªç¶å ç«ã®ãæ¬ é¥ãã«ã€ããŠèªããããšããããã¯ç¥ã®äŒŒå§¿ãšããŠåµé ããã人é¡ã«å¯ŸããçŽæ¥çãªæªéçæ»æã§ãããã¯ã¯ãã³ã®ãç§åŠãã®èåŸã§ã¯åžžã«ããã§ãã£ãã
ãã®ããã«ã«ä»£è¡šãããäžç芳ã§ã¯ã圌ãã¯äººé¡ãšå°çãæã䜿åœãè² ã£ãŠãããšå¿ããä¿¡ããŠãããä»ã®èª°ããç¡ç¥ãããŠãããã®æ±ºå®ãäžãããšãã§ããªãããã倧è¡ã«äººçã®çãæ¹ãæç€ºã§ãã髿¬¡ã®çåœäœã§ãããšä¿¡ããŠããŸãã
圌ãã¯è²ªæ¬²ãšæ¯é 欲ã«çªãåãããããµã€ã³ãã¹ã§ããç§ãã¡ã¯åœŒãã®è¡šåãã®åŽé¢ããèŠãŠããŸãããã圌ããä»ã®äººéãšåã人éã§ãããã圌ãã衚åãã®ç掻ãé¢ããŠã©ã®ããã«çããŠãããããããã°ãããããæš©åã®åº§ãç¶æã§ããªãã§ãããããªããªãã圌ããããã«éªæªã§ãããã¯äžç®çç¶ã ããã§ãã
äŸãã°ãã¢ã³ãœããŒã»ãã¡ãŠãå士ãèŠãŠãã ããã圌ã¯80æ³ã®è人ã®ããã«èŠããŸããïŒã©ãããŠãããªã«è¥ã ããèŠããã®ã§ããããïŒ
å¯è£å±€ãæå人ã¯è¥ãã远æ±ããæš©åãç¶æããããšã«å·çããŠããããã®å€ãããã€ã³ã°ãã©ããããã€ãŸãè¥è ããæ¡åãããè¡æ¶²ãæåããããšã§ãããè¡ã£ãŠããããšã¯åšç¥ã®äºå®ã§ããããã«ã¯ãåŠåçŽåã®ä¹³å ããæ¡åããããéåžžã«äžæ¯æ§ã®é«ãè¬ç©ãã¢ãã¬ãã¯ãã ããå«ãŸããŠããŸãã ãã€ã³ã°ãã©ããã - åäŸã®è¡æ¶²ããäœããã補åã®æ°èåžå Ž
圌ãã¯ãç§åŠãã®ããã«å€§éã®äººãæ»ã¬ããšãäœãšãæãããäžèœã¯ã¯ãã³ã®éçºã«å°œåããŠããããã®äžèœã¯ã¯ãã³ã¯åœŒããäœå幎ããããŠéçºããŠãããã®ã§ããããã®å€¢ã¯COVID-19ã«ãã£ãŠã€ãã«å®çŸããããšããŠããã
ç§ã¯10幎以äžãã®åé¡ãåãäžããŠããŸãããããã®ããã«ãã£ã¹ã«ãã·ã§ã³ã§é©ããããšã¯äœäžã€ãããŸããã§ããã
èªãã®ç®çã®ããã«äžç人å£ãå¶åŸ¡ããå¯äžã®æ¹æ³ã¯ã人ã ã®å¥åº·ãå¶åŸ¡ããããšã§ãããæ°å幎ã«ããã倱æãçµãŠãå šäººå£ã«ææãèå»¶ããçç©å µåšãéçºããããšã¯ã»ãŒäžå¯èœã§ããããšã圌ãã¯åŠãã ã
ãã®çç±ã¯ãç¥ã®èªç¶ã®å ç«ã·ã¹ãã ãããŸãã«ã匷åã§ããã人é¡ã«åãã£ãå®å šè£ 眮ãšããŠãããã®ç æ°ã«é©å¿ããå æããããã§ãã
éå»ã®ããã³ãããã¯ãã¯ãã»ãŒå šãŠã圌ããéçºããããšããçç©å µåšèšç»ã®å€±æã ã£ãã®ã§ã¯ãªãããšæããŸããçµå±ãå°çäžã®ãã¹ãŠã®äººã ãææãããå¯äžã®æ¹æ³ã¯ãã¯ã¯ãã³ãéããŠæ¯ãæ³šå ¥ããããšã ãšåœŒãã¯åŠãã ã®ã§ãã
ããã¯åžžã«ã¯ã¯ãã³éåã®ç®æšã§ãã£ãããéåã«åå ããã»ãšãã©ã®äººãããã«æ°ã¥ãããã¯ã¯ãã³ãå®éã«äººã ã«å¥åº·ããããããšä¿¡ããã»ã©æãã§ãã£ãã
çã®å¥åº·ã¯ãä¿å¥åœå±ããããéã§è²·ãããã®ã§ã¯ãããŸãããããã¯åµé äž»ããç§ãã¡ã«äžããããç¡åã®èŽãç©ã§ããã仿¥å°çäžã§æãå¥åº·ãªäººã ã¯ããã®çå®ãèªèããå»è¬åãæ¯ç©ã§ããããšãç¥ããªããå¯èœãªéãé ããããç¥ãåµé ããæž æœã§å®å šãªé£åãæåããæ°é®®ãªç©ºæ°ãåžãããããããåªåããããããå°æ°ã®äººã ã§ããããããå°çå·¥åŠã«ãããååŠç©è³ªã«ããå€§æ°æ±æã«ãããããã¯ãŸããŸãå°é£ã«ãªã£ãŠããŸãã
ç§ãã¡ã®å ç«ã·ã¹ãã ã®ãã©ã³ã¹ã厩ãããšãã«äœ¿ãããã«ç¥ãäžããŠãããã倩ç¶è¬ããããããããã¯èªç¶çã«ååšããäžè¬ã«ãã¹ãŠã®äººãå©çšã§ããŸãããªããªãããããã¯ç¥ãäœã£ããã®ã§ããã人éãäœã£ããã®ã§ã¯ãªããããç¹èš±ãååŸããããšãã§ããªãããã§ãã
ç§ãã¡ã¯ããã®æªéã®ãããªæŽåãã¡ã«æµæããªããã°ãªããŸããïŒå¥åº·ã¯ç¥ãããªãã«äžããŠãããæã倧åãªãã®ã§ããå¥åº·ããªããã°ãããªãã¯åœŒãã®èšããªãã«ãªããå»çå¶åºŠã®å¥Žé·ã«ãªã£ãŠããŸããŸãã
å¥åº·ããªããã°ãé å¶è ãæããããšããåã©ããç£ãããšãã人çãç²Ÿäžæ¯çããããšããç¥ãããªãããã®å°çã«éã£ãç®çãæããããšãã§ããŸããã
çµæžæŽ»åã«åå ããããã«å¿ èŠãªãèæžã«é èšãããŠããç£ã®å»å°ãããã«ããããããCOVID-19ã¯ã¯ãã³ã§ããããã®åç»ã¯ãŸãã«ãã®äºå®ãããã«èšŒæãããã®ãªã®ã§ãã
******
èªè ã®çæ§ãžïŒäžèšãŸãã¯äžèšã®ã·ã§ã¢ãã¿ã³ãã¯ãªãã¯ããŠãã ãããInstagramïŒ@crg_globalresearchïŒã§ãã©ããŒããŠãã ããããã®èšäºãã¡ãŒãªã³ã°ãªã¹ãã«è»¢éããŠãã ãããããã°ãµã€ããã€ã³ã¿ãŒããããã©ãŒã©ã ãªã©ã«ã¯ãã¹ãã¹ãããŠãã ããã
泚ç®ã®ç»åã¯HINãã
